Emerging in the field of excess body fat treatment, retatrutide represents a distinct approach. Unlike many current medications, retatrutide works as a double agonist, at once engaging both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. The simultaneous stimulation promotes various beneficial effects, li